RICHARD B PATCHETT, MD
Medical Practice at Oak Ave, Marshfield, WI
License number
Wisconsin 31233
Category
Medical Practice
Type
Ophthalmology
Address
Address
1000 N Oak Ave, Marshfield, WI 54449
Phone
(713) 387-9371
Organization information
See more information about RICHARD B PATCHETT at bizstanding.comMarshfield Clinic - Richard B Patchett MD
1000 N Oak Ave, Marshfield, WI 54449
Categories:
Ophthalmology Physicians & Surgeons
Phone:
(715) 387-5511 (Phone)
Professional information
Dr. Richard B Patchett, Marshfield WI - MD (Doctor of Medicine)
Specialties:
Ophthalmology
Address:
Marshfield Office
1000 N Oak Ave, Marshfield 54449
(715) 389-5900 (Phone)
1000 N Oak Ave, Marshfield 54449
(715) 389-5900 (Phone)
Certifications:
Ophthalmology, 1989
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Marshfield Office
1000 N Oak Ave, Marshfield 54449
Ministry Saint Joseph's Hospital
611 North Saint Joseph Ave, Marshfield 54449
Ministry Saint Michael's Hospital
900 Illinois Ave, Stevens Point 54481
1000 N Oak Ave, Marshfield 54449
Ministry Saint Joseph's Hospital
611 North Saint Joseph Ave, Marshfield 54449
Ministry Saint Michael's Hospital
900 Illinois Ave, Stevens Point 54481
Education:
Medical School
Loma Linda University
Graduated: 1983
L a Co Usc Med Center
University Louisville School Of Med
University Of Co School Of Med
Loma Linda University
Graduated: 1983
L a Co Usc Med Center
University Louisville School Of Med
University Of Co School Of Med
Richard Bryant Patchett, Marshfield WI
Specialties:
Ophthalmologist
Address:
1000 N Oak Ave, Marshfield, WI 54449
Education:
Loma Linda University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology
Richard B Patchett, Marshfield WI
Specialties:
Ophthalmology
Work:
Marshfield Clinic Marshfield
1000 N Oak Ave, Marshfield, WI 54449
1000 N Oak Ave, Marshfield, WI 54449
Education:
Loma Linda University (1983)
Adrb2 Gene Polymorphism Associated With Intraocular Pressure Response To Topical Beta-Blockers
US Patent:
2011025, Oct 13, 2011
Filed:
Jun 23, 2011
Appl. No.:
13/166845
Inventors:
Catherine Anne McCarty - Marshfield WI, US
James K. Burmester - Marshfield WI, US
Bickol N. Mukesh - Mansfield TX, US
Richard B. Patchett - Marshfield WI, US
Russell Alan Wilke - Brookfield WI, US
James K. Burmester - Marshfield WI, US
Bickol N. Mukesh - Mansfield TX, US
Richard B. Patchett - Marshfield WI, US
Russell Alan Wilke - Brookfield WI, US
Assignee:
Marshfield Clinic - Marshfield WI
International Classification:
A61K 31/5377, C12Q 1/68, A61K 31/4704, A61P 27/06, A61K 31/138, A61K 31/222
US Classification:
5142362, 514652, 514546, 514312, 435 611
Abstract:
The invention provides a single nucleotide polymorphism (SNP) rs1042714 in the human ADRB2 gene (Gln27Glu) associated with a clinically meaningful reduction in intraocular pressure (IOP) in a human following treatment with a topical beta-blocker. Nucleic acids comprising the SNP are used to screen glaucoma-afflicted individuals to thereby provide an improved method for genotype-based prescribing of beta-blockers in glaucoma management.
Adrb2 Gene Polymorphism Associated With Intraocular Pressure Response To Topical Beta-Blockers
US Patent:
2009029, Dec 3, 2009
Filed:
May 29, 2009
Appl. No.:
12/474441
Inventors:
Catherine Anne McCarty - Marshfield WI, US
James K. Burmester - Marshfield WI, US
Bickol N. Mukesh - Mansfield TX, US
Richard B. Patchett - Marshfield WI, US
Russell Alan Wilke - Brookfield WI, US
James K. Burmester - Marshfield WI, US
Bickol N. Mukesh - Mansfield TX, US
Richard B. Patchett - Marshfield WI, US
Russell Alan Wilke - Brookfield WI, US
International Classification:
A61K 31/498, C12Q 1/68, A61K 31/138, A61P 27/06
US Classification:
514249, 435 6, 514651
Abstract:
The invention provides a single nucleotide polymorphism (SNP) rs1042714 in the human ADRB2 gene (Gln27Glu) associated with a clinically meaningful reduction in intraocular pressure (IOP) in a human following treatment with a topical beta-blocker. Nucleic acids comprising the SNP are used to screen glaucoma-afflicted individuals to thereby provide an improved method for genotype-based prescribing of beta-blockers in glaucoma management.